{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:57:38Z","timestamp":1775581058070,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1307401"],"award-info":[{"award-number":["2017YFC1307401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109901","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T23:01:07Z","timestamp":1677020467000},"page":"109901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Selegiline ameliorated dyslipidemia and hepatic steatosis in high-fat diet mice"],"prefix":"10.1016","volume":"117","author":[{"given":"Zhen","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.109901_b0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12967-021-02751-3","article-title":"Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia","volume":"19","author":"Song","year":"2021","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.intimp.2023.109901_b0010","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","article-title":"Diabetic dyslipidemia","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.intimp.2023.109901_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112837","article-title":"Role of probiotics in non-alcoholic fatty liver disease: does gut microbiota matter?","volume":"11","author":"Xie","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.intimp.2023.109901_b0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/09637486.2020.1849041","article-title":"Hepatoprotective and anti-inflammatory effects of a standardized pomegranate (Punica granatum) fruit extract in high fat diet-induced obese C57BL\/6 mice","volume":"72","author":"Pfohl","year":"2021","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.intimp.2023.109901_b0025","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.biopha.2019.01.004","article-title":"Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats","volume":"111","author":"Yin","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2023.109901_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2023.109901_b0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bioorg.2017.10.001","article-title":"Sulfonyl hydrazones derived from 3-formylchromone as non-selective inhibitors of MAO-A and MAO-B: Synthesis, molecular modelling and in-silico ADME evaluation","volume":"75","author":"Abid","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2023.109901_b0040","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00702-018-1881-5","article-title":"90 years of monoamine oxidase: some progress and some confusion","volume":"125","author":"Tipton","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.intimp.2023.109901_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.676239","article-title":"Monoamine oxidase inhibitors: a review of their anti-inflammatory therapeutic potential and mechanisms of action","volume":"12","author":"Ostadkarampour","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109901_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/35.1.3025289","article-title":"Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain","volume":"35","author":"Thorpe","year":"1987","journal-title":"J. Histochem. Cytochem."},{"issue":"5","key":"10.1016\/j.intimp.2023.109901_b0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/PL00005371","article-title":"Reactive oxygen species production by monoamine oxidases in intact cells","volume":"359","author":"Pizzinat","year":"1999","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2023.109901_b0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/plac.2001.0770","article-title":"Monoamine oxidase expression and activity in human placentae from pre-eclamptic and normotensive pregnancies","volume":"23","author":"Sivasubramaniam","year":"2002","journal-title":"Placenta"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.109901_b0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0161-813X(03)00094-9","article-title":"Monoamine oxidase (MAO) in human peripheral tissues","volume":"25","author":"Billett","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2023.109901_b0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejmech.2018.01.003","article-title":"Privileged scaffolds as MAO inhibitors: retrospect and prospects","volume":"145","author":"Tripathi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2023.109901_b0075","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.biochi.2007.02.013","article-title":"Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes","volume":"89","author":"Bour","year":"2007","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.intimp.2023.109901_b0080","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/bph.14211","article-title":"Body fat reduction without cardiovascular changes in mice after oral treatment with the MAO inhibitor phenelzine","volume":"175","author":"Carpene","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2023.109901_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102904","article-title":"Metabolic effects of oral phenelzine treatment on high-sucrose-drinking mice","volume":"19","author":"Carpene","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.109901_b0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.119.259895","article-title":"Oral phenelzine treatment mitigates metabolic disturbances in mice fed a high-fat diet","volume":"371","author":"Mercader","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.109901_b0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/jat\/bkaa058","article-title":"Detection of l-methamphetamine and l-amphetamine as selegiline metabolites","volume":"45","author":"Shin","year":"2021","journal-title":"J. Anal. Toxicol."},{"issue":"18","key":"10.1016\/j.intimp.2023.109901_b0100","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1111\/bph.14437","article-title":"Selegiline reduces adiposity induced by high-fat, high-sucrose diet in male rats","volume":"175","author":"Nagy","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109901_b0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clnu.2021.11.004","article-title":"Folic acid oversupplementation during pregnancy disorders lipid metabolism in male offspring via regulating arginase 1-associated NOS3-AMPKalpha pathway","volume":"41","author":"Liu","year":"2022","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.intimp.2023.109901_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020480","article-title":"Dietary platycodon grandiflorus attenuates hepatic insulin resistance and oxidative stress in high-fat-diet induced non-alcoholic fatty liver disease","volume":"12","author":"Ke","year":"2020","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.intimp.2023.109901_b0115","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bbalip.2018.08.004","article-title":"Intake of stigmasterol and beta-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet","volume":"1863","author":"Feng","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"8","key":"10.1016\/j.intimp.2023.109901_b0120","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1039\/D0FO00436G","article-title":"Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet","volume":"11","author":"Guo","year":"2020","journal-title":"Food Funct."},{"issue":"16","key":"10.1016\/j.intimp.2023.109901_b0125","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1111\/bph.14713","article-title":"Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease\/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity","volume":"176","author":"Rao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109901_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104563","article-title":"Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors","volume":"108","author":"Panova","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.intimp.2023.109901_b0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.coph.2017.04.003","article-title":"Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease","volume":"33","author":"Deshwal","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109901_b0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/ml200196p","article-title":"Molecular insights into human monoamine oxidase B inhibition by the glitazone anti-diabetes drugs","volume":"3","author":"Binda","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"41","key":"10.1016\/j.intimp.2023.109901_b0145","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1021\/acs.biochem.0c00477","article-title":"Targeting lipid metabolism in liver cancer","volume":"59","author":"Alannan","year":"2020","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.intimp.2023.109901_b0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1309\/JXWUM661T8VT1ETX","article-title":"Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease","volume":"127","author":"Ahmed","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109901_b0155","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate Immunity and Inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2023.109901_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112556","article-title":"Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response","volume":"255","author":"Yang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.109901_b0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2011.07.029","article-title":"An effective novel delivery strategy of rasagiline for Parkinson's disease","volume":"419","author":"Fernandez","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.intimp.2023.109901_b0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ndt\/gfq445","article-title":"Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin","volume":"26","author":"Chaaya","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.intimp.2023.109901_b0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10787-022-00945-9","article-title":"Repurposing monoamine oxidase inhibitors (MAOI) for the treatment of rheumatoid arthritis possibly through modulating reactive oxidative stress mediated inflammatory cytokines","volume":"30","author":"Sur","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2023.109901_b0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxlet.2017.01.005","article-title":"Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells","volume":"268","author":"Cui","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"21","key":"10.1016\/j.intimp.2023.109901_b0185","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.21037\/atm-20-2426","article-title":"Protective effect of selegiline on cigarette smoke-induced oxidative stress and inflammation in rat lungs in vivo","volume":"8","author":"Cui","year":"2020","journal-title":"Ann Transl Med"},{"issue":"9","key":"10.1016\/j.intimp.2023.109901_b0190","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00210-017-1392-1","article-title":"Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats","volume":"390","author":"Wahdan","year":"2017","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"19","key":"10.1016\/j.intimp.2023.109901_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911059","article-title":"Neuroprotective function of rasagiline and selegiline, inhibitors of type B monoamine oxidase, and role of monoamine oxidases in synucleinopathies","volume":"23","author":"Naoi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2023.109901_b0200","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/0006-2952(92)90345-J","article-title":"Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats","volume":"44","author":"Carrillo","year":"1992","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109901_b0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00702-011-0666-x","article-title":"The effect of selegiline on total scavenger capacity and liver fat content: a preliminary study in an animal model","volume":"119","author":"Bekesi","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"18","key":"10.1016\/j.intimp.2023.109901_b0210","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.109901_b0215","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JPD-212976","article-title":"Monoamine oxidase-b inhibitors for the treatment of parkinson's disease: past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Parkinsons. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.109901_b0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00002826-200009000-00006","article-title":"Adverse drug reactions to selegiline: a review of the French pharmacovigilance database","volume":"23","author":"Montastruc","year":"2000","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109901_b0225","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jnnp.63.2.228","article-title":"Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease","volume":"63","author":"Churchyard","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2023.109901_b0230","doi-asserted-by":"crossref","unstructured":"Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom, BMJ 307(6902) (1993) 469-72.","DOI":"10.1136\/bmj.307.6902.469"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:05:35Z","timestamp":1761588335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":46,"alternative-id":["S1567576923002217"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109901","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selegiline ameliorated dyslipidemia and hepatic steatosis in high-fat diet mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109901"}}